Harrow, Inc. Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
Harrow, Inc. (HROW) reported Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation of 1.61 thousand shares for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-23.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation · last filed 2016-03-23
- Harrow, Inc. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2015 was 1.61K shares.
| Period end | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 12 month |
|---|---|
| 2015-12-31 | 1.61K shares 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |